Goldman Sachs reports sale of 105,807 Attovia Therapeutics shares worth $2.22 million
Reuters2026/08/14 01:52- Goldman Sachs reported trading activity in Attovia Therapeutics common stock on Aug. 5, 2026.
- Purchased 85,000 shares at USD 21.
- Sold 105,807 shares at prices from USD 20.84 to USD 22.11.
- Reported holdings from that activity fell to zero by end of Aug. 5.
- On Aug. 6, it acquired 2.44 million shares via preferred-stock conversions, lifting beneficial ownership to 3.02 million shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Diversified Energy (DEC.US) is reportedly close to acquiring Birch for $1.7 billion, as the oil and gas M&A boom continues to heat up.
According to reports, Diversified Energy (DEC.US) is in advanced negotiations to acquire Elliott-backed oil and gas company Birch Resources, with the deal expected to exceed $1.7 billions in cash.
Mabuchi Motor targets 3%-5% DOE dividends, pledges progressive payouts through 2030
Mabuchi Motor says H1 ordinary income tops forecast on weaker yen gains
Mabuchi Motor sets interim dividend at JPY 35 a share
Crypto prices
More
